Supernus Pharmaceuticals said it is acquiring Sage Therapeutics, the distressed maker of a drug for postpartum depression, ...

The links between ultra-processed food and higher risk of diabetes will be the focus of the first wave of Kennedy’s national ...

In today's Pharmalittle roundup, we're reading about a Sarepta setback with its Duchenne drug, the FDA workload causing a ...

To prevent ovarian cancers, fallopian tube removal is on an upsurge — and diagnostic manuals are finally catching up.

An IVF doctor and clinic founder writes that his industry needs increased governmental oversight and more comprehensive ...

The law shouldn’t force pregnant people to assume greater duties to their fetuses than parents have to their children.

Trump health officials signal eased FDA rules for rare disease gene therapy, but concerns linger over safety, oversight, and ...

Sarepta said it was halting shipments of its Duchenne gene therapy for patients who can no longer walk, following the death ...

To finance tax cuts, a GOP bill would reduce Medicaid payments to hospitals by $321 billion, hitting both blue and red states ...

To encourage robust, good-faith discussion about issues raised in First Opinion essays, STAT publishes selected Letters to ...

Join us for Open Doors – As the biopharma landscape accelerates through scientific innovation, economic pressures, and evolving global dynamics, where should companies place their bets to drive ...

Me, which became a household name for its genetic testing services, is set to emerge from bankruptcy as a nonprofit.